Stuart A. Fine files SEC Form 4 disclosures for AKESIS PHARMACEUTICALS, INC.. They have made 1 open-market trade across 1 company since 2008, most recently 2008-09-23.
CIK 0001312681
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $185K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AKES.OB | 136,300 | — |
Shares reported on the most recent Form 4, priced at the 2008-10-16 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKES.OB | BUY | 2008-07-24 | 2008-10-16 | $0.91 | $185K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.